Jaguar Health, Inc.

JAGXNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
2.75 USD
↘ 0.74 (21.30%)AT CLOSE (11:59 AM EDT)
2.71
↘ 0.04 (1.45%)
POST MARKET (AS OF 06:19 PM EDT)
Post Market
AS OF 06:19 PM EDT
2.71
↘ 0.04 (1.45%)
🟢Market: OPEN

Jaguar Health, Inc. (JAGX) is currently trading at $2.71. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest JAGX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Sep 17, 2026.

Open?$3.70
High?$3.70
Low?$2.35
Prev. Close?$3.49
Volume?256.3K
Avg. Volume?556.6K
VWAP?$2.85
Rel. Volume?0.46x
Bid / Ask
Bid?$2.19 × 100
Ask?$3.17 × 100
Spread?$0.98
Midpoint?$2.68
Valuation & Ratios
Market Cap?99.8K
Shares Out?5.2M
Float?4.5M
Float %?91.8%
P/E Ratio?N/A
P/B Ratio?0.02
EPS?-$120.75
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
47
Market Cap
101.1K
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.jaguar.health
Listed
2015-05-13
Address
200 PINE STREET SUITE 400
SAN FRANCISCO, CA 94104
Phone: 415-371-8300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
90
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-18.41Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.37%Elevated
Short Interest?242.0K
Days to Cover?1.6
Free Float4.5M
Avg Daily Volume151.8K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.69Weak
Quick Ratio?0.40Weak
Cash Ratio?0.15Low
Debt/Equity?2.35High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.02CHEAP▾
P/S?
S&P
97
0.00CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.43CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-792.4%WEAK▾
ROA?
S&P
3
-153.3%WEAK▾
Cash Flow & Enterprise
FCF?$-6726000
Enterprise Value?$11.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist